We propose to use an antibody-coated microfluidic surface-capture device, the Herringbone CTC-chip, to isolate hepatocellular carcinoma (HCC) circulating tumor cells (CTCs) from venous blood. Successful isolation of these cells from the venous blood of HCC patients has the potential to substantially improve current medical practice by enabling early detection and monitoring of therapy in HCC patients. Survival from HCC is entirely dependent on early detection whether its detection of the primary tumor or recurrence after treatment. Screening, early diagnosis and detection of recurrence have been formidable challenges and despite massive worldwide research efforts, the five-year survival rate of HCC patients remains to be poor. We propose to develop and optimize the CTC-chip for HCC CTC isolation (Aim 1). We will then determine the diagnostic accuracy of the CTC analysis compared to biopsy evaluation of unknown liver masses (Aim 2). The critical value of Aim 2 is to determine the sensitivity and the specificity of the technology to detect HCC CTCs in patients with cancer (n=40) and without cancer (n=40).

Public Health Relevance

Detection and enrichment of rare tumor cells from whole blood using a micro-chip technology is a groundbreaking achievement in clinical medicine and is already paving the way for personalized medicine. These cells are powerful indicators of tumor burden. We propose to develop and optimize the micro-chip technology to capture liver cancer circulating tumor cells to demonstrate its feasibility and utility in diagnosis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Research Grants (R03)
Project #
5R03CA172738-02
Application #
8721366
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Rinaudo, Jo Ann S
Project Start
2013-09-01
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Khurana, Aditya; Hangge, Patrick T; Albadawi, Hassan et al. (2018) The Use of Transarterial Approaches in Peripheral Arteriovenous Malformations (AVMs). J Clin Med 7:
Hangge, Patrick T; Gupta, Nikhil; Khurana, Aditya et al. (2018) Degree of Left Renal Vein Compression Predicts Nutcracker Syndrome. J Clin Med 7:
Bhan, Irun; Mosesso, Kelly; Goyal, Lipika et al. (2018) Detection and Analysis of Circulating Epithelial Cells in Liquid Biopsies From Patients With Liver Disease. Gastroenterology 155:2016-2018.e11
Adler, Cameron; Hangge, Patrick T; Albadawi, Hassan et al. (2018) Multi-Detector Computed Tomography Imaging Techniques in Arterial Injuries. J Clin Med 7:
Wallace, Alex; Albadawi, Hassan; Hoang, Peter et al. (2017) Statins as a preventative therapy for venous thromboembolism. Cardiovasc Diagn Ther 7:S207-S218
Sugi, Mark D; Albadawi, Hassan; Knuttinen, Grace et al. (2017) Transplant artery thrombosis and outcomes. Cardiovasc Diagn Ther 7:S219-S227
Albadawi, Hassan; Witting, Avery A; Pershad, Yash et al. (2017) Animal models of venous thrombosis. Cardiovasc Diagn Ther 7:S197-S206
Fleck, Drew; Albadawi, Hassan; Wallace, Alex et al. (2017) Below-knee deep vein thrombosis (DVT): diagnostic and treatment patterns. Cardiovasc Diagn Ther 7:S134-S139
Hoang, Peter; Wallace, Alex; Sugi, Mark et al. (2017) Elastography techniques in the evaluation of deep vein thrombosis. Cardiovasc Diagn Ther 7:S238-S245
Czaplicki, Christopher; Albadawi, Hassan; Partovi, Sasan et al. (2017) Can thrombus age guide thrombolytic therapy? Cardiovasc Diagn Ther 7:S186-S196

Showing the most recent 10 out of 21 publications